One step closer to influenza vaccine inclusiveness

Area of Science:

• * Virology and Immunology
• * Public Health and Epidemiology

Background:

• * Influenza virus infections cause significant acute respiratory illness, particularly in pediatric populations, leading to high morbidity and mortality.
• * Risk factors for severe flu complications include young age, advanced age, pregnancy, chronic conditions (e.g., asthma), and immunodeficiency.
• * Current flu vaccination strategies target these vulnerable groups.

Purpose of the Study:

• * To review current influenza vaccine indications for vulnerable populations.
• * To support inclusive flu vaccination strategies.
• * To provide a foundation for future universal influenza vaccine approaches.

Main Methods:

• * Review of current scientific literature and guidelines on influenza vaccination.
• * Analysis of indications and contraindications for available flu vaccines.
• * Focus on vulnerable populations and vaccination inclusiveness.

Main Results:

• * Inactivated influenza vaccine (IIV), recombinant influenza vaccine (RIV), and live-attenuated influenza virus (LAIV) are available with specific usage guidelines.
• * Certain populations (pediatric, elderly, pregnant, immunocompromised, those with chronic diseases) are prioritized for vaccination due to higher risk.
• * Precautions and contraindications exist for different vaccine types and patient groups.

Conclusions:

• * Current influenza vaccination recommendations aim to protect high-risk groups.
• * Ensuring vaccine access and adherence in vulnerable populations is crucial for public health.
• * This review supports the ongoing development towards a universal influenza vaccine strategy.